Background: Pompe disease is a rare, progressive neuromuscular disorder caused by a deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA), resulting in glycogen accumulation primarily in skeletal and cardiac muscle (1,2). Enzyme replacement therapy (ERT) has been the cornerstone of treatment for Pompe disease, with alglucosidase alfa as t
Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2465 Reached4 Comments6 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes